Accumulating studies have shown that CDKs and other protein kinases are potential therapeutic targets in GBM and other cancers due to the vital roles these kinases play in driving the cell cycle and eventual tumor progression [1,20,27,32,38,51,52]. Here, WEE1 is linked to cancer.